Triggering receptor expressed on myeloid cells - 1 (Trem-1) on blood neutrophils is associated with cytokine inducibility in human E. coli sepsis

Diagnostic Pathology

Volumn 8, Issue 1, 2013, Pages

  van Bremen, Tobias ^a   Drömann, Daniel ^a   Luitjens, Karin ^a   Dodt, Christoph ^b   Dalhoff, Klaus ^a   Goldmann, Torsten ^c   Schaaf, Bernhard ^a,d  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Medical Clinic München Bogenhausen   (Germany)

^c Member of the German Center for Lung Research   (Germany)

^d Dortmund Clinic   (Germany)

Author keywords

Endotoxin tolerance; Hyporesponsiveness; Neutrophils; Pattern recognition receptors (PRR); Sepsis; Triggering receptor expressed on myeloid cells 1 (Trem 1)

Indexed keywords

CD14 ANTIGEN; CYTOKINE; HLA DR ANTIGEN; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MEMBRANE PROTEIN; TLR2 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2; TREM1 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; ESCHERICHIA COLI INFECTION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MALE; MICROBIOLOGY; MONOCYTE; NEUTROPHIL; PROSPECTIVE STUDY; SEPSIS; UPREGULATION;

AGED; ANTIGENS, CD14; CASE-CONTROL STUDIES; CYTOKINES; ESCHERICHIA COLI INFECTIONS; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MEMBRANE GLYCOPROTEINS; MONOCYTES; NEUTROPHILS; PROSPECTIVE STUDIES; RECEPTORS, IMMUNOLOGIC; SEPSIS; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

MLCS; MLOWN;

EID: 84873741147     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-8-24     Document Type: Article

References (30)

1. Hagel S, Brunkhorst FM. Sepsis. Intensivmed 2011, 48:57-73.
2. Manthey CL, Vogel SN. Interactions of lipopolysaccharide with macrophages. Immunol Ser 1994, 60:63-81.
3. Sessler CN, Bloomfield GL, Fowler AA. Current concepts of sepsis and acute lung injury. Clin Chest Med 1996, 12:213-235.
4. Munford RS, Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001, 163:316-321.
5. West MA, Heagy W. Endotoxin tolerance: a review. CritCare Med 2002, 30(1 Suppl.):S64-S73.
6. Härter L, Mica L, Stocker R, Trentz O, Keel M. Increased expression of toll-like receptor-2 and -4 on leukocytes from patients wit sepsis. Shock 2004, 22:403-409. 10.1097/01.shk.0000142256.23382.5d, 15489631.
7. Lehner MD, Morath S, Michelsen KS, Schumann RR, Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J Immunol 2001, 166:5161-5167.
8. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, Nakanishi K, Kimoto M, Miyake K, Takeda K, Akira S. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 2000, 164:3476-3479.
9. Oku R, Oda S, Nakada TA, Sadahiro T, Nakamura M, Hirayama Y, Abe R, Tateishi Y, Ito M, Iseki T, Hirasawa H. Differential pattern of cell-surface and soluble TREM-1 between sepsis and SIRS. Cytokine 2013, 61:112-117. 10.1016/j.cyto.2012.09.003, 23046618.
10. Uehara A, Sato T, Iwashiro A, Yokota S. PR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2. Diagn Pathol 2009, 4:23. 10.1186/1746-1596-4-23, 2717921, 19594951.
11. Schaaf B, Luitjens K, Goldmann T, van Bremen T, Sayk F, Dodt C, Dalhoff K, Droemann D. Mortality in human sepsis is associated with downregulation of Toll-like receptor 2 and CD14 expression on blood monocytes. Diagn Pathol 2009, 4:12. 10.1186/1746-1596-4-12, 2672063, 19371402.
12. Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, Payen D. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med 2009, 37:2746-2752. 10.1097/CCM.0b013e3181ab858a, 19707128.
13. Barraud D, Gibot S. Triggering receptor expressed on myeloid cell 1. Crit Care Clin 2011, 27:265-279. 10.1016/j.ccc.2010.12.006, 21440201.
14. Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000, 164:4991-4995.
15. Wang F, Liu S, Wu S, Zhu Q, Ou G, Liu C, Wang Y, Liao Y, Sun Z. Blocking TREM-1 signaling prolongs survival of mice with Pseudomonas aeruginosa induced sepsis. Cell Immunol 2012, 272:251-258. 10.1016/j.cellimm.2011.10.006, 22055202.
16. Gibot S, Massin F, Marcou M, Taylor V, Stidwill R, Wilson P, Singer M, Bellingan G. TREM-1 promotes survival during septic shock in mice. Eur J Immunol 2007, 37:456-466. 10.1002/eji.200636387, 17230441.
17. Bone RC. The sepsis syndrome. Definition and general approach to management. Clin Chest Med 1996, 17:175-181. 10.1016/S0272-5231(05)70307-5, 8792059.
18. Dalhoff K, Hansen F, Drömann D, Schaaf B, Aries SP, Braun J. Inhibition of neutrophil apoptosis and modulation of the inflammatory response by granulocyte colony-stimulating factor in healthy and ethanol-treated human volunteers. J Infect Dis 1998, 178:891-895. 10.1086/515350, 9728567.
19. Kovach MA, Standiford TJ. The function of neutrophils in sepsis. Curr Opin Infect Dis 2012, 25:321-327. 10.1097/QCO.0b013e3283528c9b, 22421753.
20. Tessarz AS, Weiler S, Zanzinger K, Angelisová P, Horejsí V, Cerwenka A. Non-T cell activation linker (NTAL) negatively regulates TREM-1/DAP12-induced inflammatory cytokine production in myeloid cells. J Immunol 2007, 178:1991-1999.
21. Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, Colonna M, Modlin RL. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol 2003, 170:3812-3818.
22. Su L, Liu C, Li C, Jiang Z, Xiao K, Zhang X, Li M, Yan P, Feng D, Xie L. Dynamic changes in serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and its gene polymorphisms are associated with sepsis prognosis. Inflammation 2012, 35:1833-1843. 10.1007/s10753-012-9504-z, 22798017.
23. Derive M, Bouazza Y, Sennoun N, Marchionni S, Quigley L, Washington V, Massin F, Max JP, Ford J, Alauzet C, Levy B, McVicar DW, Gibot S. Soluble TREM-like transcript-1 regulates leukocyte activation and controls microbial sepsis. J Immunol 2012, 188:5585-5592. 10.4049/jimmunol.1102674, 22551551.
24. Jeong SJ, Song YG, Kim CO, Kim HW, Ku NS, Han SH, Choi JY, Kim JM. Measurement of plasma sTREM-1 in patients with severe sepsis receiving early goal-directed therapy and evaluation of its usefulness. Shock 2012, 37:574-578. 10.1097/SHK.0b013e318250da40, 22395243.
25. Gómez-Piña V, Soares-Schanoski A, Rodríguez-Rojas A, Del Fresno C, García F, Vallejo-Cremades MT, Fernández-Ruiz I, Arnalich F, Fuentes-Prior P, López-Collazo E. Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol 2007, 179:4065-4073.
26. Fumeaux T, Dufour J, Stern S, Pugin J. Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines. Intensive Care Med 2004, 30:2028-2037. 10.1007/s00134-004-2429-8, 15368036.
27. Adib-Conquy M, Cavaillon JM. Host inflammatory and anti-inflammatory response during sepsis. Pathol Biol (Paris) 2012, 60:306-313.
28. Tsujimoto H, Ono S, Efron PA, Scumpia PO, Moldawer LL, Mochizuki H. Role of toll-like receptors in the development of sepsis. Shock 2008, 29:315-321.
29. Trimmel H, Luschin U, Köhrer K, Anzur C, Vevera D, Spittler A. Clinical outcome of critically ill patients cannot be defined by cutoff values of monocyte human leukocyte antigen-DR expression. Shock 2012, 37:140-144. 10.1097/SHK.0b013e31823f1866, 22089188.
30. Palazzo SJ, Simpson T, Schnapp LM. Triggering receptor expressed on myeloid cells type 1 as a potential therapeutic target in sepsis. Dimens Crit Care Nurs 2012, 31:1-6. 10.1097/DCC.0b013e31823a5298, 22156803.